SL Science Holding Ltd (SLBT) Form 424B3 — Aug 14, 2026
SL Science Holding Limited (Nasdaq: SLBT) filed a prospectus registering the resale of up to 1,040,000 ordinary shares by selling shareholders — 780,000 shares currently held plus 260,000 issuable upon conversion of series A preferred shares. The company will receive no proceeds and pays the registration expenses, with the six-month lock-up expiring on or about December 12, 2026 (six months after the June 12, 2026 business combination closing). The shares trace to a PIPE financing in which investors bought 780,000 units at $10.00 per unit (roughly $7.8 million gross) alongside the de-SPAC merger with Horizon Space Acquisition II Corp.
Key figures
- Shares Offered
- 1040000
- Last Sale Date
- 2026-08-12
- Lockup Expiry
- on or about 2026-12-12 (six months after June 12, 2026 business combination closing)
- Last Sale Price
- 2.67
- Wang Shares Owned
- 333832129
- Pipe Price Per Unit
- 10
- Pipe Gross Proceeds
- $7.8 million implied (780,000 Units x $10.00, per-unit price as stated)
- License Royalty Rate
- 7% to 15% of total sales revenue
- Patent Transfer Price
- 949771
- Wang Voting Power Percent
- 59.53%
- Cyto Arm Milestone Payments
- up to $4.1 million
- Wang Cyto Arm Indirect Stake
- 12.6%
- Jy Bio Med Milestone Payments
- up to $37.0 million
- Resale Shares Currently Held
- 780000
- Customer Concentration Fy2025
- 95.3% of revenue from two customers
- Resale Shares From Preferred Conversion
- 260000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.